Blog Topic
Health Economics
The Queens’ Secret Annamese Fertility Herb Resolves an Unmet Medical Need – on track for FDA Botanical Drug Approval
The rise of botanical drugs and consumer trends in self-care
Empowering patients to take control of their health data: A DIAmond session at DIA San Diego 2019
Examining the challenges surrounding health data ownership, patient privacy, and building trust between patients and organizations handling their data.
Rare Diseases - A Growing Focus for Healthcare Product Developers
An overview of the challenges faced by the pharma industry in tackling rare diseases and the shift towards patient-centricity
Do Outcome Measures in Pain Trials Hamper Drug Development?
A look at the challenges in developing new analgesics, the debate on clinical trial outcomes, and potential ways to view pain differently.
Individualising targets in diabetes: NICE or not NICE?
A discussion of individualising glycaemic targets for adults with type 1 diabetes
How do we really know what people want in terms of healthcare?
Addressing social preferences in healthcare policy and resource allocation
Why bother with writing assistance for HEOR studies? Surely we can all communicate…
Discover the importance of effective HEOR communication, the role of publications, and the need for clear, comprehensive reporting to inform decisions
Is there room for the iPad in health economics?
The article explores the role of the iPad in health economics, its impact on medical communication, and the challenges it faces
What are journal editors looking for from health economists?
Learn best practices for health economists to submit research to clinical journals
Using euphemisms and jargon in health economics
A discussion on the use of euphemisms and jargon in health economics, their benefits and drawbacks, and when they should be used
Understanding risk: the patient’s perspective
Learn about the inexact nature of medicine, the role of risk perception in healthcare decisions, and the importance of patient-doctor communication
Putting the squeeze on pharma pricing in the EU
A look into the intricacies of pharmaceutical pricing policy in Europe and its connection to pricing for other everyday items like cars and football viewing.
Subscribe to our newsletter
Get the latest news straight to your inbox.
Discover the Power of Communication with Rx
Embark on your medcomms journey with Rx today and experience the difference of working with a world-class medical communications agency.